Results for tag: "Castrate Sensitive Prostate Cancer Drug"

The Castrate Sensitive Prostate Cancer Drug market is a subset of the larger Prostate Cancer Drug market. These drugs are used to treat prostate cancer that is still sensitive to androgen deprivation therapy (ADT). ADT is a form of hormone therapy that reduces the amount of testosterone in the body, which can slow the growth of prostate cancer. Castrate Sensitive Prostate Cancer Drugs are used to further reduce the amount of testosterone in the body, and can also be used to reduce the size of the tumor. These drugs can be administered orally, intravenously, or through injections. Some companies in the Castrate Sensitive Prostate Cancer Drug market include Astellas Pharma, Bayer, Janssen Pharmaceuticals, Merck, and Pfizer. Show Less Read more